GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

70
GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088

Transcript of GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Page 1: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

GROUP4REG NO:

10/06/GS/300210/06/GS/299310/06/GS/299410/06/GS/298810/06/PS/318610/06/GS/ 3088

Page 2: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

CellulitisPresented by 10/06/GS/2993

Cellulitis is an infection of the deeper layers of the skin and the underlying tissue

Etiology• It is caused by a bacterial skin infection of Streptococci

throught the:•cut •graze •burn •animal, human or insect bite •puncture wound •skin ulcer

Risk factors• obesity and Weak immunity• diabetes and circulation problems • chickenpox and shingles •intravenous drug use •having previous episodes of cellulitis

Page 3: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Clinical presentation• It begins as a small area of– tenderness – Swelling– redness tend to spread to adjacent skin.

• The affected person may develop a – fever – chills – sweats – swollen lymph nodes– swollen glands near the area of infected skin.

Page 4: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 5: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

pathogenesis• Invasion of S. aureus and S. pyogenes by using

1. M-protein to inhibit phagocytosis2. Protein F to bind the M protein to fibronectin3. lipoteichoic acid for adherence4. hyaluronic acid capsule to inhibit phagocytosis5. invasins ( as streptokinase,streptodornase and hyaluronidaseThen,there is Overcomes of the defensive cells in our body,which includes

mast cells, eosinophils,basophils, and neutrophils as immuno response.

Page 6: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• DiagnosisAssessing the symptoms and examining the skin.

Management• Antibiotics to control Infection• Analgesic for temperature or vomiting• Self-care• Drink plenty of water to prevent dehydration.• If your leg is affected by cellulitis, keep it raised. • Pain relief• Paracetamol and ibuprofen.

Page 7: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Ludwig’s anginaConnective tissue infection, of the floor of the mouth, usually

occurring in adults with concomitant dental infections.

Aetiology• It is caused by• bacteria factors include staphylococcus spp,streptococcus spp

and enterobacter• Mandibular fracture • penetrating injuryPathogenesis• The anaerobic and aerobic bacteria produce the endotoxin like• protease,hyalironidase,collagenase that cause synergic effect and

allow th rapid spread of cellulitis

Page 8: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Clinical features• Bilateral infection of

sublingual,submandibular spaces• Brawnly oedema with elevation of the

tongue,airway abstruction and very little pus.

Page 9: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 10: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis• We find • Redness,swelling of the upper neck,chin,floor

of the mouth.• the tongue may be swollen or out of place.• Culture of fluid from the tissue may show

bacteria

Page 11: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Managment• Maintainance of airway• High dose antibiotic such as:

• Penicillin or penicillin-like

• Removal of saurce infection(tooth extraction)• Parenteral hydration,early surgical,drainage.

• Referance: wikpedia.com• Altavista.com

Page 12: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Gingival hyperplasiapresented by10/0,6/GS/3002

• refers to excessive growth of the gums, Etiology:Imflammatory enlargment:• Chronic imflammation caused by prolonged exposure to bacterial plaque.Drug -induced enlargment • Anticonvulsants, such as phenytoin, valproate, phenobarbital, vigabatrin, topiramate and primidone.• Calcium channel blockers, such as verapamil and nifedipine• Immunosuppresants such as cyclosporineEnlargment associated with systemic factors such as: • Pregnancy• Puberty • Vitamin C deficiency.Systemic disease :• Leukemia• Granulomatous disease• Neoplasm:

– Begnin and malignant

Page 13: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

PathogenesisThe pathogenesis of drug –induced hyperplasia is uncertain. the interaction between drug and/or metabolite, with the gingival

fibroblasts begin the action. Factors like age, genetic predisposition, pharmacokinetic variables,

plaque-induced inflammatory and immunological changes and activation of growth factors intervien in protection or damaging.

these genetic factors which give rise to fibroblast heterogeneity, gingival inflammation, and pharmacokinetic variables appear to be significant in the expression of gingival overgrowth.

Page 14: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

DiagnosisIt is based on IFN –gamma stimulated Gene expression using

oligonucleotide microorganism.This determine difference between benign and malgnant gingival

hyperplasia based on evolution by IFN-gamma complexClinical presentation• firm, benign and painless swelling in the gums • The doctor sees for bleeding in the gums.• He also notes the level of mouth discomfort due to the enlargement. He

notices if there are any slowly enlarging mass or masses along the gingival margin.

Page 16: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Managment

• brushing and flossing • .chlorhexidine • Ultrasonic treatments • Erythromycin • Discontinuation of cousative drug

• Referance • Wikipedia.com

Page 17: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Granuloma pyogenicum• is a primarily oral disease which appears as an overgrowth of tissue due to irritation physical

trauma or hormonal factorsEtiologyIrritation caused by• poor oral hygiene • Chronic oral irritants • Bacterial infection• Traumatic injury• Hormonal factors

Page 18: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Pathogenesis

• inflammatory cytokines have been implied to play the major roles .

• their links to female steroid hormones still remain to be elucidated.

Page 19: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Clinical presentation• color ranging from red/pink to purple, and can be smooth or

lobulated

Management

• surgical excision. For gingival lesions, • scaling adjacent teeth to remove any calculus and plaque

that may be a source of continuing irritation is recommended

Page 20: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 21: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Chondromaby 10/06/GS/3088

• A chondroma is a benign tumor formed in cartilage.• Etiology:Unknown causePathogenesis:This tumor is thought to arise from primitive element

of the bone marrow or mesenchymal cells.Most are also associated with a translocation of

chromosome 11and 22.

Page 22: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Clinical features

• swelling or the sensation of a lump which is fixed to the underlying bone.

• Pain may appear as the tumor grows and impinges on the surrounding structures.

• The tumor may remain symptomless and may go undetected

Page 23: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis: X rays shows the tumor as an area of decreased

density within the involved bone. The remaining bone may be thinned out and expanded.

Managment:• Surgery• Incidentally discovered tumors that have no

symptoms require no treatment except for regular observation.

Page 24: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 25: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Osteoma

• Etiology:The cause is unknown,But trauma ,Infections

and developmental defect have been suggested as possible causes.

Clinical presentation:Clinically,soft tissue osteoma appears as a well

defined,assymptomatic,hard tumor covered by a thin and smooth

normal epithelium.

Page 26: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Pathogenesis

• Is a benign tumor consisting of mature compact or cancellous bone.osteomas may be classified either periosteal occuring on the surface of bone or endosteal,occuring in the bone. Althought,the osteoma may also occur in the facial bone,such as the sinus areas.the osteoma is slow growing but may eventuallly reach larger sizes causing expasion and deformity.

Page 27: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis• histopathology examination.

Managementsurgial excision.

• Reference:general and oral pathology for dental hygienist by Leslie De

Long,NancyW.Burkhart.

Page 28: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 29: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Lipoma by:10/06/GS/2988

is a benign tumor of adipose tissue that occurs more commonly between 40-60years of ages. The buccal mucosa and tongue are commonly the predominant sites in adults

AETIOLOGYAs with many tumours the aetiology of lipomas remains obscure. The repeated mild trauma may trigger the proliferation of fatty tissue and finally causes a lipoma

Page 30: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

PATHOGENESISThe pathogenesis of lipoma is still unclear

despite its close similary to normal adipose tissue.

It is presumed to occur in obese individuals

Page 31: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Clinical Features• slowly enlarging, soft, smooth-surfaced mass of

the submucosal tissues • yellow or pink surface discoloration for

superficial• Painless• Well defined tumor• Varying in size from a few millimeters to several

centimeters(a mucosal oral lipoma may increase to 5-6 cm)

Page 32: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis

• Histopathological examination

Page 33: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• MANAGEMENT

• Conservative surgical removal(excision) is the treatment of choice for oral lipoma.

• REFERENCES

• Wikepedia.com

• Color atlas of oral diseases

Page 34: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Lipoma pictures

Page 35: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• NEUROFIBROMA• Neurofibroma is a benign overgrow of nerve

tissue origin.• CLINICAL FEATURES

• Painless well-defined• Firm tumors• Covered by normal epithelium• Size changes from several millimeters to several

centimeters

Page 36: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• PATHOGENESIS• The solitary neurofibroma may be found on

any nerve where it presents as a slow growing.

Page 37: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• DIAGNOSIS• Is based on a series of clinical criteria.• Histopathological examination

Page 38: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• MANAGEMENT

• Total or partial resection of neurofibromatous lesions (Surgical excision)

• REFERENCE

• Wikepedia.com

• Color atlas of oral diseases

Page 39: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Fig 1. A: intraoral view showing a protruding lesion from tooth 2.4 to the ipsilateral tuberosity

Page 40: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Lymphangiomapresented by 10/06/Ps/3186

Lymphangiomas are malformations of the lymphatic system, which is the network of vessels responsiblefor

returning to the venous ystem excess fluid from tissues

Etiology The direct cause of lymphangioma is a blockage of the lymphatic system as a fetus develops, although symptoms may not become visible until after the baby is born. This blockage is thought to be

caused by a number of factors, including maternal alcohol use and viral infections during pregnancy.

Page 41: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

classification• Lymphangiomas have traditionally been classified into three subtypes:

capillary and cavernous lymphangiomas and cystic hygromas. This classification is based on their microscopic characteristics. A fourth subtype, the hemangiolymphangioma is also recognized.

1. Capillary lymphangiomas : Capillary lymphangiomas are composed of small, capillary-sized lymphatic vessels and are characteristically located in the epidermis 2.Cavernous lymphangiomas: Composed of dilated lymphatic channels, cavernous lymphangiomas characteristically invade surrounding tissues. 3.Cystic hygromas :Cystic hygromas are large, macrocystic lymphangioma. 4.Hemangiolymphangioma As suggested by their name, hemangiolymphangiomas are lymphangiomas with a vascular component.

Page 42: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Lymphangiomas may be also classified based on the size of their cyst:

• 1.macrocystic• 2. microcystic• 3.mixed

• CLINICAL FEATURE

• They resembles to the clusters of small blisters ranging in color from pink to dark red.They are benign and do not require medical treatment, although some patients may choose to have them surgically removed for cosmetic reasons

Page 43: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Common site relevent in dentistry

• typically on the neck, tongue and lips, and vary widely in size, ranging from as small as several wide.

• Diagnosis• Cases of lymphangioma are diagnosed by histopathology inspection. In

prenatal cases, cystic lymphangioma is diagnosed using an ultrasound

Page 44: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Pathogenesis

• lymphatic cisterns in the deep subcutaneous plane are separated from the normal network of lymph vessels.

• They communicate with the superficial lymph vesicles through vertical dilated lymph channels.

• The typical history of Lymphangioma shows a small number of vesicles on the skin at birth or shortly after.

• In subsequent years, they tend to increase in number, and the area of skin involved continues to expand.

• Vesicles or other skin abnormalities may not be noticed until several years after birth.

Page 45: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Treatment and prognosis• Drainage• Lymphangioma can be healed when treated with a flashlamp • Treatment for cystic lymphangioma involves the removal of

the abnormal tissue;• Surgical removal of the tumor is the typical treatment

provided, with the understanding that additional removal procedures will most likely be required as the lymphangioma grows.

• References:Wikipedia,the free Encyclopedia

Page 46: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 47: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Hemangioma• It is the abnormal buildup of blood vessels in

the skin or internal organ.• It is benignEtiolgy:• Vascular malformation

Page 48: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

The pathogenesis • is still not understood. • But there are factors :• hormonal and mechanical influences that

affect the abnormal proliferation of endothelial cells

• the primary, causative defect in hemangiogenesis remains unknown and no genetic alteration has been implicated

Page 49: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

ClInical features The common site :the are seen on the tongue,lips and buccal

mucosa. They are lesion with blue discoloration. Diagnosis

• The use of aglass slide(diascopy) Management

• Non symptomatic:non reaction• symptomatic: surgecal excision, cryotherapy, sclerosing and

embolisation

Page 50: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 51: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Burkett's lymphoma by 10/06/Gs/2994

• High grade malignant B-cell lymphoma arising from germinal cell or lymph node.or or MALT

• Aetiology:the cause is unknown but epstein Barr virus can take place.

• Associated wieh maralia

Page 52: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Clinical presentation:

• Because of rapid growth of Burkett's tumour,patient may quickly manifest significant metabolic derangement and renal function supairment.

It can present also skin nodules, acute lymphocytic leukemia with fever,anaemia bleeding and adenopathy.

Page 53: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 54: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Pathogenesis• In immunosuppressed individuals, such as

patients with AIDS patients treated with immunosuppressive agents in the

setting of organ transplantation, suppressed by normal T-cell immunity. With diminished T-cell function,

• Then, there is an infection of EBV which may progress to malignant lymphoma.

• And as EBV infection correlates with CNS tropism of lymphoma.

• The tumor displayed diffuse and strong immunoreactivity for smooth muscle actin, H-caldesmon; focal positivity for desmin; and strong and diffuse positivity for Epstein-Barr virus RNA on in situ hybridization.

Page 55: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis• biopsy of the tumor mass for histopathology,

immunochemistry and flow cytometry.

Page 56: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Management • Monitor serumchemistries,intravenous

antibiotics• References:Ali H kambar

Page 57: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Kaposi's sarcomaEtiology• human herpes virusClinical features • nodules and blochetes(that may be red brown

or black),lesion easily damaged by chewing and bleeding, interference eating and speaking.

Page 58: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Pathogenesis• the tumor is high vascular containing

abnormally dense and irregular blood vessels with leak red blood cells into surrounding tissue.

• These high vascularity give the dark color, inflammation around the tumor then swelling and pain occur.

Page 59: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Diagnosis• biopsy and microscopic examination to find the spindle cells.• detection of Kaposi's simplex herpes virus(KSHV protein

LANA in tumor cell)

• Management:• Treat the cause of immune system dysfunction• radiotherapy • cryosurgery• interferon alpha, liposomal.• References:Ali H kambar

Page 60: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

LymphangiomaLymphangiomas are malformations of the lymphatic

system, which is the network of vessels responsiblefor returning to the venous ystem excess fluid from tissues

Etiology The direct cause of lymphangioma is a blockage of the

lymphatic system as a fetus develops, although symptoms may not become visible until after the baby is born. This blockage is

thought to be caused by a number of factors, including maternal alcohol use and viral infections during pregnancy.

Page 61: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• classification• Lymphangiomas have traditionally been classified into three subtypes:

capillary and cavernous lymphangiomas and cystic hygromas. This classification is based on their microscopic characteristics. A fourth subtype, the hemangiolymphangioma is also recognized.

1. Capillary lymphangiomas : Capillary lymphangiomas are composed of small, capillary-sized lymphatic vessels and are characteristically located in the epidermis 2.Cavernous lymphangiomas: Composed of dilated lymphatic channels, cavernous lymphangiomas characteristically invade surrounding tissues. 3.Cystic hygromas :Cystic hygromas are large, macrocystic lymphangioma. 4.Hemangiolymphangioma As suggested by their name, hemangiolymphangiomas are lymphangiomas with a vascular component.

Page 62: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Lymphangiomas may be also classified based on the size of their cyst:

• 1.macrocystic• 2. microcystic• 3.mixed

• CLINICAL FEATURE

• They resembles to the clusters of small blisters ranging in color from pink to dark red.They are benign and do not require medical treatment, although some patients may choose to have them surgically removed for cosmetic reasons

Page 63: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Common site relevent in dentistry

• typically on the neck, tongue and lips, and vary widely in size, ranging from as small as several wide.

• Diagnosis• Cases of lymphangioma are diagnosed by histopathology inspection. In

prenatal cases, cystic lymphangioma is diagnosed using an ultrasound

Page 64: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Pathogenesis• finding lymphatic cisterns(waterproof or water collection) in the

deep subcutaneous plane are separated from the normal network of lymph vessels. They communicate with the superficial lymph vesicles through vertical, dilated lymph channels

• Microscopically, the vesicles in lymphangioma are greatly dilated lymph channels that cause the papillary dermis to expand

• The typical history of Lymphangioma shows a small number of vesicles on the skin at birth or shortly after. In subsequent years, they tend to increase in number, and the area of skin involved continues to expand. Vesicles or other skin abnormalities may not be noticed until several years after birth

Page 65: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Treatment and prognosis• Drainage• Lymphangioma can be healed when treated with a flashlamp • Treatment for cystic lymphangioma involves the removal of the

abnormal tissue;• Surgical removal of the tumor is the typical treatment provided,

with the understanding that additional removal procedures will most likely be required as the lymphangioma grows.

• References:Wikipedia,the free Encyclopedia

Page 66: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.
Page 67: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Hemangioma• It is the abnormal buildup of blood vessels in

the skin or internal organ.• It is benignEtiolgy:• Vascular malformation

Page 68: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

Clinical features The common site :the are seen on the tangwe,lips and buccal

mucosa. They are lesion with blue discoloration.

Diagnosis• The use of aglass slide(diascopy)

Management• Non symptomatic:non reaction• symptomatic: surgecal excision,cryotherapy,sclerosing and

emboliation

Page 69: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.

• Pathogenesis• Is still not understood. • but growth factors :• hormonal and mechanical influences affect

the abnormal proliferation of endothelial cells in hemangioma

• the primary, causative defect in hemangiogenesis remains unknown and no genetic alteration has been implicated.

• Referance:Dr Isyagi and wikipedia

Page 70: GROUP4 REG NO: 10/06/GS/3002 10/06/GS/2993 10/06/GS/2994 10/06/GS/2988 10/06/PS/3186 10/06/GS/ 3088.